M33 Growth I L.P. sold TOI
September 4, 2025 · Form 4 insider transaction
M33 Growth I L.P. sold 6,018,168 shares of Starling Oncology Inc at $3.09 per share, a transaction worth $18.60M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
6,018,168
Price
$3.09
Total value
$18.60M
InsiderM33 Growth I L.P.
Role—
CompanyStarling Oncology Inc (TOI)
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 4, 2025
Filing dateSeptember 5, 2025
Shares owned after7,932,389
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
M33 Growth I GP LLC ("M33 LLC") is the general partner of M33 Growth I L.P. ("M33 LP") and may be deemed to beneficially own the shares held by M33 LP but disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein.